Glaukos CORP (GKOS) — 13F Filings Explorer (Q2 2026)

GKOS ranks #1693 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

366 institutions disclose a position in GKOS, but none treat it as a major bet — even Braidwell LP, its most concentrated holder, allocates just 3.1% of its own portfolio to it.

Ken Griffin has added to its GKOS position for two straight quarters, increasing it by $194.3M to reach $203.9M today.

David Shaw has trimmed its GKOS position for two straight quarters, cutting it by $55.0M while still holding $8.0M.

GKOS is down 0.5% today, but institutions show net buying of $1.7B this quarter — a divergence between today's price move and the underlying institutional flow.

GKOS reported a net loss of $188.0M over the trailing twelve months.

• Not yet profitable — net loss of $188.0M over the trailing twelve months
• Revenue grew 41.5% year over year
• Net income declined year over year, from -$92.8M to -$188.0M
• Operating cash flow was negative, using $14.8M in cash
• Current ratio of 4.69x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.36x equity — within a conventional range